今日VC

LONDON, June 23, 2009–GlaxoSmithKline (LSE: GSK) and Chroma Therapeutics Limited announced today a collaboration to develop macrophage-targeted compounds using Chroma’s proprietary esterase-sensitive motif (ESM) technology, which adds amino acid esters to compounds with the aim of targeting the compounds to specific cells in the inflammatory disease process.
Under the terms of the collaboration with GSK’s [...]

CHICAGO -GTCR, one of the nation’s leading private equity firms, today announced it has agreed to invest $200 million in Ironshore Inc., a leading specialty insurance company. GTCR will serve as lead investor in this financing that will involve a number of existing investors and will collectively provide the company with up to $300 million [...]

MASSY, France – Alchimer S.A., a leading provider of cost-saving wet deposition processes for interconnections in advanced 3D-packaging applications, announced today that it has raised an additional $10 million in new financing to expand customer-support programs and pursue new IP development.
Alchimer’s D round of funding includes both previous and new investors, including AGF, CEA [...]

WALTHAM, Mass., June 19, 2009– I-Therapeutix announced today that it has closed a $15 million dollar Series C financing. The round was led by Polaris Venture Partners in Waltham, MA, with continued participation by existing investors, Versant Ventures and SV Life Sciences.
The proceeds will be used to commercialize I-ZIP(R) Ocular Bandage in the United [...]

CAMBRIDGE, Mass., June 19, 2009– Living Proof, a technology-based beauty company, headquartered in Cambridge, Massachusetts, announced today it has secured $9 million of financing to fuel growth, technology pipeline, and international expansion.
Living Proof was founded by Polaris Venture Partners, a venture capital firm with an extraordinary 25-year track record, and Dr. Robert Langer, one [...]